Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-16 Sale |
2023-03-17 6:15 pm |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
357 | $13.43 | $4,795 | 71,868 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-17 6:04 pm |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
5,313 | $13.44 | $71,404 | 46,826 (Direct) |
View |
| 2023-03-15 Sale |
2023-03-17 6:02 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
8,791 | $13.76 | $120,943 | 1,126,692 (Indirect Direct) |
View |
| 2023-03-08 Sale |
2023-03-10 5:13 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
5,570 | $15.02 | $83,654 | 1,090,286 (Indirect Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 4:58 pm |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
5,000 | $15.12 | $75,600 | 34,289 (Direct) |
View |
| 2023-02-15 Sale |
2023-02-17 4:54 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
8,000 | $15.28 | $122,240 | 1,095,856 (Indirect Direct) |
View |
| 2023-02-08 Sale |
2023-02-10 4:54 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
9,000 | $15.14 | $136,260 | 1,103,856 (Indirect Direct) |
View |
| 2023-01-23 Sale |
2023-01-25 5:49 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
4,856 | $15.45 | $75,025 | 1,112,856 (Indirect Direct) |
View |
| 2023-01-06 Sale |
2023-01-24 6:13 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
411 | $15 | $6,165 | 1,131,490 (Indirect Direct) |
View |
| 2023-01-19 Sale |
2023-01-20 6:44 pm |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
5,000 | $14.56 | $72,800 | 39,289 (Direct) |
View |
| 2023-01-18 Sale |
2023-01-20 6:41 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
8,240 | $14.57 | $120,080 | 1,118,123 (Indirect Direct) |
View |
| 2023-01-11 Sale |
2023-01-13 6:47 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
3,904 | $15.11 | $58,989 | 1,126,363 (Indirect Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 8:26 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
1,634 | $15.16 | $24,773 | 1,130,267 (Indirect Direct) |
View |
| 2022-12-21 Sale |
2022-12-22 6:02 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
8,000 | $14.57 | $116,560 | 1,131,901 (Indirect Direct) |
View |
| 2022-12-16 Sale |
2022-12-20 6:35 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
535 | $15.01 | $8,030 | 1,139,901 (Indirect Direct) |
View |
| 2022-12-15 Sale |
2022-12-16 4:55 pm |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
5,000 | $14.64 | $73,200 | 44,289 (Direct) |
View |
| 2022-12-14 Sale |
2022-12-16 4:51 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
6,420 | $15.08 | $96,814 | 1,140,436 (Indirect Direct) |
View |
| 2022-12-02 Sale |
2022-12-06 5:52 pm |
Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer |
1,154 | $16.9 | $19,503 | 8,723 (Direct) |
View |
| 2022-12-02 Sale |
2022-12-06 5:49 pm |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
1,154 | $16.9 | $19,503 | 13,723 (Direct) |
View |
| 2022-11-30 Sale |
2022-12-01 8:09 pm |
Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer |
2,347 | $16.62 | $39,017 | 33,797 (Direct) |
View |
| 2022-11-30 Sale |
2022-12-01 7:58 pm |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
2,347 | $16.62 | $39,017 | 38,797 (Direct) |
View |
| 2022-11-17 Sale |
2022-11-18 4:12 pm |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
5,000 | $16.54 | $82,700 | 49,289 (Direct) |
View |
| 2022-11-16 Sale |
2022-11-18 4:09 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
8,000 | $16.86 | $134,853 | 1,146,856 (Indirect Direct) |
View |
| 2022-11-15 Sale |
2022-11-17 5:30 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
6,857 | $17.72 | $121,506 | 49,729 (Direct) |
View |
| 2022-11-09 Sale |
2022-11-14 4:25 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
9,000 | $17.87 | $160,830 | 1,154,856 (Indirect Direct) |
View |
| 2022-10-20 Sale |
2022-10-28 4:24 pm |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
5,000 | $15.92 | $79,589 | 54,289 (Direct) |
View |
| 2022-10-19 Sale |
2022-10-21 4:23 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
8,000 | $16.92 | $135,349 | 1,163,856 (Indirect Direct) |
View |
| 2022-10-12 Sale |
2022-10-14 4:32 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
9,000 | $15.91 | $143,194 | 1,171,856 (Indirect Direct) |
View |
| 2022-09-21 Sale |
2022-09-23 6:08 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
8,000 | $16.31 | $130,475 | 1,180,856 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-15 Exercise |
2023-03-17 6:15 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
5,097 | $0 | 71,868 (Direct) |
View |
| 2023-03-15 Exercise |
2023-03-17 6:04 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
4,462 | $0 | 46,826 (Direct) |
View |
| 2023-03-15 Exercise |
2023-03-17 6:02 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
11,299 | $0 | 1,126,692 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 7:31 pm |
N/A 2033-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer |
71,795 | $0 | 71,795 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 7:29 pm |
N/A 2033-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
71,795 | $0 | 71,795 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 7:28 pm |
N/A 2033-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Trevejo Jose M. Chief Medical Officer |
76,251 | $0 | 76,251 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 7:26 pm |
N/A 2033-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
80,708 | $0 | 80,708 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 7:25 pm |
N/A 2033-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
80,708 | $0 | 80,708 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 7:24 pm |
N/A 2033-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
67,257 | $0 | 67,257 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 7:23 pm |
N/A 2033-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
168,142 | $0 | 168,142 (Direct) |
View |
| 2022-12-02 Option Award |
2022-12-06 5:59 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-11-29 Exercise |
2022-12-01 8:09 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer |
10,251 | $0 | 33,797 (Direct) |
View |
| 2022-11-29 Exercise |
2022-12-01 7:58 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
10,251 | $0 | 38,797 (Direct) |
View |
| 2022-11-10 Other |
2022-11-14 4:34 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director |
223,957 | $0 | 375,068 (Indirect) |
View |
| 2022-10-06 Option Award |
2022-10-11 4:23 pm |
N/A 2032-10-05 |
Tarsus Pharmaceuticals Inc. | TARS | Morrison Scott W Director |
18,000 | $0 | 18,000 (Direct) |
View |